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background: Heart failure (HF) is a clinical syndrome associated with diverse metabolic disturbances. Recent studies suggest that failing 
heart trough secretion of soluble myostatin may induce skeletal muscle wasting in HF patients and skeletal muscle plays an important role in 
pathogenesis of exercise intolerance in patients with chronic HF. The prevalence of sarcopenia is reported as 5-13% in general 60-70year-olds and 
as about 20% in patients with chronic HF, however, the prevalence and clinical significance of sarcopenia in patients with acute decompensated HF 
(ADHF) remain unclear. We investigated the association between sarcopenia and ADHF. 
methods: We assessed lean body mass by dual energy X-ray absorptiometry in 52 patients with ADHF (age 71±10, left ventricular ejection fraction 
(LVEF) 38±16%, B-type natriuretic peptide (BNP) levels on admission 540 [275-1161] pg/ml). Sarcopenia was defined as the appendicular skeletal 
muscle mass index (appendicular skeletal muscle mass/height2) 2 standard deviations below the mean of young healthy Japanese subjects (<6.87 
kg/m2 in male, <5.46 kg/m2 in female). 
results: Appendicular skeletal muscle mass index significantly correlated with age, (r=-0.27, P=0.04), male sex (r=0.43, P=0.002), body mass 
index (r=0.50, P<0.001), heart rate (r=-0.31, P=0.02), and BNP levels (r=-0.27, P=0.04). The prevalence of sarcopenia was 54%. ADHF patients with 
sarcopenia had more severe HF symptoms (New York Heart Association class- 2.8±0.6 versus 2.5±0.5, p=0.03), higher BNP levels (656 [372-1326] 
versus 353 [234-813], p=0.009), and higher rate of clinical scenario 2-3 (43% versus 13%, p=0.02) than those without sarcopenia. Multivariate 
logistic regression analysis demonstrated that sarcopenia (odds ratio (OR): 5.5, 95%-confidence interval (CI): 1.1-28.6, P=0.04), LVEF (OR: 
0.95, 95%-CI: 0.90-0.99, P=0.03), and hemoglobin level (OR: 0.66, 95%-CI: 0.44-0.99, P=0.04) independently correlated with higher BNP levels 
(>400pg/ml) in ADHF patients. 
conclusions: Sarcopenia is frequently observed in ADHF patients and is associated with severity of HF in ADHF, irrespective of LV systolic function 
and other clinical profile. 
